To investigate the potential involvement of SIRT1 in the reversal of sorafenib resistance mediated by miR-124-3p.1, we investigated the effects of sorafenib on three HCC cell lines following siRNA-mediated knockdown of SIRT1. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.